In people with type 2 diabetes, GLP-1 receptor agonists are linked to a modest increase in flare-ups of rheumatoid arthritis, but it is not known whether this is due to the drug directly affecting...
Evidence from Studies
No evidence studies found yet.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.